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Nuclear sensing of viral DNA has emerged as an
essential step in innate immune responses against
herpesviruses. Here, we provide mechanistic insight
into host recognition of human cytomegalovirus
(HCMV) and subsequent immune evasion by this
prominent DNA virus. We establish that the inter-
feron-inducible protein IFI16 acts as a nuclear
DNA sensor following HCMV infection, binding viral
DNA and triggering expression of antiviral cyto-
kines via the STING-TBK1-IRF3 signaling pathway.
The HCMV tegument protein pUL83 inhibits this
response by interacting with the IFI16 pyrin domain,
blocking its oligomerization upon DNA sensing and
subsequent immune signals. pUL83 disrupts IFI16
by concerted action of its N- and C-terminal do-
mains, in which an evolutionarily conserved N-termi-
nal pyrin association domain (PAD) binds IFI16.
Additionally, phosphorylation of the N-terminal
domain modulates pUL83-mediated inhibition of
pyrin aggregation. Collectively, our data elucidate
the interplay between host DNA sensing and HCMV
immune evasion, providing targets for restoring anti-
viral immunity.
INTRODUCTION
An essential step to trigger host innate immune responses
against viral infections is sensing of intracellular viral nucleic
acids. It is widely accepted that sensing of viral DNAs by cellular
sensor proteins occurs in the cytoplasm. However, recent find-
ings from several laboratories, including ours, have established
the concept of nuclear sensing, as nuclear viral DNAs can be
recognized by a DNA sensor—the interferon-inducible protein
IFI16 (Kerur et al., 2011; Li et al., 2012; Orzalli et al., 2012).
Nuclear sensing was shown to be critical for eliciting interferon
response (Li et al., 2012; Orzalli et al., 2012) and inflammatory
response (Ansari et al., 2013; Kerur et al., 2011; Singh et al.,
2013) following herpesvirus infection.
During coevolution with their hosts, viruses have acquired
effective mechanisms for blocking host immune signaling.
Defining these mechanisms is essential for understanding virusCell Host &pathogenesis and developing new therapeutics. The human
cytomegalovirus (HCMV), a b herpesvirus, causes global epi-
demics and complications in AIDS patients and organ transplant
recipients, and is a major cause of birth defects (Cheeran et al.,
2009). While nucleoside analogs are used to treat HCMV infec-
tions, the emergence of drug-resistant strains underscores the
demand for novel antiviral strategies (Jabs et al., 1998).
The HCMV major tegument protein pUL83 (also known as
phosphoprotein pp65) is thought to play critical roles in immune
evasion. Present at >2,000 copies permature virion, pUL83 is the
most abundant virion component (Varnum et al., 2004). It is
deposited into infected cells immediately after entry, thereby
quickly subverting both adaptive and innate immunity. pUL83
was shown to block antigen presentation (Gilbert et al., 1996)
and activation of natural killer cells (Arnon et al., 2005) and to
suppress the induction of antiviral cytokines (Abate et al.,
2004; Browne and Shenk, 2003). Consistently, guinea pig CMV
lacking the UL83 homolog was attenuated in viral dissemination
and pathology (McGregor et al., 2004). However, the mecha-
nisms underlying pUL83-mediated innate immune evasion
remain elusive. pUL83may target antiviral host proteins, yet their
identities or downstream signaling pathways remain unknown.
Using a proteomic approach during HCMV infection, we re-
ported that nuclear pUL83 interacts with two interferon-inducible
proteins from the PYHIN family—IFI16 and IFIX (Cristea et al.,
2010). The pUL83-IFI16 interaction is required for activating viral
gene transcription at the major immediate-early promoter
(MIEP). However, it is unclear if this interaction is also connected
to the pUL83-dependent immune evasion.
Recent reports showed that IFI16 can detect viral DNA in both
the cytoplasm and nucleus (Horan et al., 2013; Johnson et al.,
2013; Kerur et al., 2011; Li et al., 2012; Orzalli et al., 2012; Singh
et al., 2013; Unterholzner et al., 2010) and act as a virus-restrict-
ing factor (Gariano et al., 2012). The sensing ability of IFI16,
which is influenced by its subcellular distribution, is modulated
by acetylations within its nuclear localization signal (Li et al.,
2012). As herpesviruses DNA is protected by viral capsids in
the cytoplasm prior to nuclear exposure, nuclear sensing is a
critical aspect of defense against these nuclear replicating
viruses. In endothelial cells, nuclear IFI16 can assemble inflam-
masomes during infection with Kaposi sarcoma-associated
herpesvirus (KSHV), leading to secretion of proinflammatory
interleukins (Kerur et al., 2011). In U2OS cells and fibroblasts,
nuclear IFI16 senses herpes simplex virus-1 (HSV-1) DNA,
triggering type I interferon (IFN) response (Li et al., 2012; Orzalli
et al., 2012) and inflammasome formation (Johnson et al.,Microbe 14, 591–599, November 13, 2013 ª2013 Elsevier Inc. 591
Figure 1. pUL83 Antagonizes IFI16-Mediated Antiviral Response
(A) mRNA levels of cytokines in HFFs infected with WT or DUL83 HCMV or mock infected, at 3 or 6 hpi (moi = 5). Data are shown as mean ± SEM, n = 3.
(B) Protein levels of IRF-1, IRF-3, NF-kB p65, and other markers were measured by western blot in total cell lysates and nuclear fractions of HFFs infected
as in (A).
(C) mRNA levels of cytokines in HFFs infected with UV-treatedWT orDUL83 HCMV, at 6 hpi (moi = 5). Western blots show IE-1, pUL83, and loading control (actin)
protein levels.
(D) HFFs stably expressing pUL83-Flag or control were infected with mock or DUL83 strain. Western blots show protein levels for pUL83 and IFI16. IF images
show nuclear localization of pUL83-Flag. mRNA levels of cytokines were measured by qPCR as in (A).
(legend continued on next page)
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degradation, leaked HSV-1 DNA can be detected by cytosolic
IFI16 (Horan et al., 2013). Cytosolic IFI16 also detects trans-
fected DNA, inducing type I IFN in a STING-dependent manner
(Unterholzner et al., 2010).
While these results highlight IFI16 as a critical antiviral factor
during herpesvirus infection, our finding that pUL83 targets
IFI16 raises the question of whether IFI16 also acts as a DNA
sensor during HCMV infection. Furthermore, the mechanisms
involved in HCMV immune evasion remain to be further eluci-
dated. Here, we aim to define the roles of IFI16 during HCMV
infection and the mechanisms utilized by pUL83 for suppressing
innate immunity. First, we establish that IFI16 and pUL83
play opposing roles in regulating HCMV-induced cytokines.
Next, we identify conserved domains that directly mediate the
pUL83-IFI16 interaction. We demonstrate that pUL83 seques-
ters the IFI16 pyrin domain by concerted action of its N and C
termini, blocking nuclear IFI16 oligomerization. We determine
that pUL83 has similar inhibitory effects on all nuclear PYHIN
proteins (i.e., IFI16, IFIX, and MNDA). Finally, we identify phos-
phorylation sites on pUL83 and show that site-specific phos-
phorylation by host kinases compromises pUL83-mediated
pyrin interference. Altogether, this work defines a previously
unrecognized mechanism underlying HCMV immune evasion,
identifying a critical molecular hub that determines the outcome
of host defense and viral pathogenesis.
RESULTS
The Host Sensor IFI16 and Viral Protein pUL83 Act in
Opposition to Regulate Host Innate Immune Responses
during HCMV Infection
To confirm the immunosuppressive function of pUL83, we
compared innate immune responses in human foreskin fibro-
blasts (HFFs) infected with either wild-type (WT, Ad169) or
DUL83mutant HCMV at amultiplicity of infection (moi) of 5 (here-
inafter), which was selected to facilitate induction of immune
response and comparison with other studies on pUL83 (Abate
et al., 2004; Browne and Shenk, 2003). Antiviral responses
weremonitored at early stages of infection, 3 and 6 hr post infec-
tion (hpi), bymeasuring: (1) the expressions of antiviral cytokines,
IFN-b, CXCL10, CCL5, and CCL20 by RT-qPCR; and (2) the
nuclear levels of transcription factors (NF-kB, IRF-1, and IRF-3)
by western blot. The DUL83 strain induced antiviral cytokines
10-fold higher than the WT strain (Figure 1A). This correlated
with increased nuclear translocation of IRF-1 and NF-kB, and
with phosphorylations of IRF-1 and IRF-3—markers of active im-
mune signaling (Figure 1B and see Figure S1A available online).
Notably, the DUL83 strain did not induce a higher inflammasome
activity compared to the WT strain, reflected by caspase-1
cleavage (Figures 1B and S1B). As pUL83 is also required for
optimal expression of immediate-early (IE) proteins (Cristea
et al., 2010), of which IE2 can block cytokine expression (Taylor
and Bresnahan, 2005, 2006), we next assessed the independent(E) Endogenous IFI16, STING, TBK-1, IRF-3, and MAVS were stably knocked dow
strain were measured as in (A).
(F) Protein levels for IRF-1, NF-kB p65, and other markers in nuclear fraction or t
See also Figure S1.
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UV-irradiated to inactivate viral gene expressions (Figure 1C).
Following infections of HFFs, the UV-treated DUL83 strain
induced 2- to 3-fold higher levels of antiviral cytokines (IFN-b,
CXCL10, and CCL5) at 6 hpi than UV-treated WT HCMV (Fig-
ure 1C). Therefore, pUL83 has cytokine-blocking function that
is independent of IE proteins. To test if pUL83 alone can coun-
teract antiviral response, we stably expressed pUL83-Flag or
vector control in HFFs and infected the cell lines with the
DUL83 strain (Figure 1D). Overexpressed pUL83 reduced the ex-
pressions of antiviral cytokines (IFN-b, CXCL10, and CCL5, Fig-
ure 1D; IL-6, Figure S1C) at 6 hpi, confirming a role for pUL83 that
may be complemented by other viral factors during infection.
Together, these results support the notion that pUL83 is critical
for dampening innate antiviral response during HCMV infection.
As we previously observed that pUL83 associates with IFI16
during infection (Cristea et al., 2010), we hypothesized that
this interaction underlies its immune evasive functions and
that IFI16 acts as a DNA sensor during HCMV infection. This
would predict that IFI16 is required for cytokine induction in
the absence of pUL83. Indeed, shRNA knockdown of endoge-
nous IFI16 and infection with the DUL83 strain significantly
reduced cytokine expression (IFN-b, CXCL10, IL-6, CCL5,
CCL2, and CCL20) and impeded nuclear translocations of
IRF-1 andNF-kBwhen compared to control knockdown (Figures
1E and 1F). We next studied the downstream signaling pathway
through which IFI16 may regulate this immune response.
Components of the DNA sensing pathway, STING, TBK-1, and
IRF3, shown to be important during HSV-1 infection (Orzalli
et al., 2012; Unterholzner et al., 2010), were individually silenced
by shRNA, and the cell lines were infected with the DUL83 strain.
As a result, we observed significantly compromised induction of
antiviral cytokines and reduced nuclear translocation of IRF-1
and NF-kB (Figures 1E and 1F). In contrast, silencing MAVS, a
component of RNA sensing pathways (Seth et al., 2005), did
not adversely affect antiviral response, supporting the specific
engagement of DNA sensing. These results demonstrate that
IFI16 and the STING-TBK1-IRF3 DNA sensing pathway are crit-
ical for eliciting antiviral response against HCMV infection in the
absence of pUL83.
Next, we tested if IFI16 can recognize HCMV DNA during
infection. ChIP assays at 6 hpi showed that endogenous IFI16
specifically recognized HCMV DNA at numerous loci, but not
host chromosomal DNA (Figure 2A). This is consistent with our
report that nuclear IFI16 binds HCMV MIEP in infected HFFs
(Cristea et al., 2010). Altogether, our results establish IFI16 as a
DNA sensor during HCMV infection, binding viral DNA and
triggering expression of antiviral cytokines. The opposing
roles of pUL83 and IFI16, in conjunction with their physical inter-
action, indicate that pUL83 may act as a critical viral factor to
inhibit IFI16-mediated DNA sensing and antiviral response. In
contrast to HSV-1 (Orzalli et al., 2012), HCMV infection did not
reduce the level of IFI16 (Figure 1B), suggesting a distinct
mode of inhibition.n in HFFs by shRNA. mRNA levels of cytokines in response to mock or DUL83
otal lysates were measured by western blot.
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Figure 2. pUL83 Blocks Nuclear Pyrin Aggregation
(A) ChIP assays test the association of endogenous IFI16 with HCMV DNA and host DNA in infected HFFs.
(B) Constructs of pUL83, IFI16, and other PYHIN proteins.
(C) CoIP assays of pUL83-Flag interaction with IFI16 constructs.
(D) CoIP assays of pUL83 interaction with pyrin domains of PYHIN proteins.
(E) 293T cells were transfected with plasmids (1:5) of Pyrin-GFP and mCherry or pUL83-mCherry. Direct fluorescent images illustrate PY-GFPs.
(F) As in (E), cells from randommicroscopy fields were analyzed for PY-GFP distributions. (Bars) Percentages of diffuse (yellow) or aggregation (blue) patterns as
mean ± SEM.
(G) As in (E), bars show IFI16-PY-GFP distributions as a function of the pUL83-mCherry/mCherry ratio.
(H) HEK293T cells transiently transfected with GFP alone or GFP fusions with full-length (FL), PY, or HIN domains of IFI16, in the presence or absence of
exogenous pUL83. Cell lysates were crosslinked, and the oligomerization status was assessed by western blotting with an anti-GFP antibody.
(I) Western blot shows migration of endogenous IFI16 in infected HFFs crosslinked with glutaraldehyde. Protein levels in total lysates prior to crosslinking are
shown.
See also Figure S2 and Movie S1.
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Nuclear PYHIN Proteins
To explore how pUL83 inhibits IFI16 function, we mapped its
binding site within IFI16. We constructed GFP fusions with full-
length (FL) IFI16, the pyrin (PY) domain, or the HIN domains
and performed coimmunoprecipitation (coIP) experiments with594 Cell Host & Microbe 14, 591–599, November 13, 2013 ª2013 ElspUL83-Flag in HEK293T cells (Figure 2B). pUL83 only interacted
with the FL or PY domain, but not with the HIN domains or GFP
alone (Figure 2C). Therefore, the PY domain is both necessary
and sufficient for pUL83 binding, and the DNA-binding HIN
domains are not targeted. Indeed, ChIP assays showed that
endogenous IFI16 bound HCMV DNA independent of pUL83evier Inc.
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domain of IFI16.
As pyrin domains are also present within other PYHIN pro-
teins—IFIX, MNDA, and AIM2—similar PY-GFP constructs
were tested for pUL83 interaction. Interestingly, pUL83 bound
the PY of all nuclear PYHIN proteins (IFI16, IFIX, and MNDA),
but not AIM2-PY (Figure 2D). Sequence alignment showed that
nuclear PY domains are distantly related to AIM2-PY (Fig-
ure S2A). CoIP assays with inflammasome adaptor ASC showed
a similar division among PY domains, as only AIM2-PY binds
ASC (Figure S2B), consistent with a previous report (Hornung
et al., 2009). Therefore, the nuclear PY domains form a distinct
subgroup from AIM2-PY. Together, these data indicate that the
pUL83-PY interaction is a general mean for HCMV to target
nuclear PYHIN proteins.
pUL83 Blocks the Ability of Pyrin Domains to Form
Nuclear Oligomers
Strikingly, the pyrin domains assembled into distinct aggregation
patterns in transfected cells (Figure 2E, rows 1, 3, 5, and 7;
Movies S1A–S1D). The PY of IFI16, IFIX, and AIM2 formed fila-
ments with variable lengths. IFI16-PY filaments were shorter
and clustered within discrete puncta. IFIX and AIM2 PY filaments
formed extensive networks in the nucleus or cytoplasm, respec-
tively; their filaments could also loop or branch (Figure S2C). In
contrast, the MNDA-PY aggregates were not filamentous and
were less discrete. Previously, we observed that full-length
IFI16-GFP did not form filamentous aggregates under unstimu-
lated conditions (Li et al., 2012), consistent with the autoinhibi-
tion of PY by HIN domains in resting state (Jin et al., 2012).
The PY aggregation may reflect an active state, serving as a
structural platform for signal amplification during DNA sensing.
To test the impact of pUL83 on PY aggregations, we coex-
pressed pUL83-mCherry with the pyrin proteins. Strikingly,
pUL83 effectively dissipated PY aggregations for IFI16, IFIX,
and MNDA, but not for AIM2 (Figure 2E, rows 2, 4, 6,
and 8; Movies S1E–S1H). Furthermore, filamentous networks
of AIM2-PY were predominantly cytoplasmic, being rarely
observed in the nucleus, and were not disrupted by pUL83 (Fig-
ure S2D). Forced nuclear localization of AIM2-PY by an exoge-
nous NLS still resulted in prominent oligomerization, even in
the presence of pUL83 (Figure S2E). These data support the
notion that pUL83 does not target AIM2-PY regardless of local-
ization. Coexpression of mCherry alone did not affect aggrega-
tions, demonstrating that the inhibition is specific to pUL83.
These results were validated by quantification in over 100 cells
(Figure 2F). Compared to mCherry alone, pUL83 drastically
reduced the percentages of cells displaying PY aggregations
for IFI16, IFIX, and MNDA, but not for AIM2. Importantly, the
pUL83-mediated inhibition was dose dependent (Figures 2G
and S2F), supporting the specific engagement of pUL83 binding
in PY interference.
Finally, we tested the effect of pUL83 on full-length endoge-
nous IFI16 during HCMV infection. Endogenous IFI16 remained
nuclear and did not display filamentous patterns during HCMV
infection (Figure S2G), consistent with our report (Cristea et al.,
2010). Similar nuclear localization was observed during HSV-1
infection (Orzalli et al., 2012), while another study reported partial
cytoplasmic IFI16 (Johnson et al., 2013). The HIN domains mayCell Host &modulate PY behavior, reducing the degree of multimerization.
Therefore, we adopted a crosslinking assay similar to those pre-
viously used to show that AIM2 (Fernandes-Alnemri et al., 2009)
or RNase L (Han et al., 2012) oligomerize upon activation. First,
we tested the oligomerization of FL IFI16 in an overexpression
model. 293T cells were transfected with GFP-tagged FL IFI16
or the PY or HIN domains and subjected to crosslinking in the
presence or absence of cotransfected pUL83-Flag (Figure 2H).
Only the FL and the PY displayed oligomerization, but not the
HIN domains or GFP alone, confirming that PY is the oligomeri-
zation domain in IFI16. Consistent with the interactions of FL and
PY with pUL83, their oligomerization was effectively dissipated
by pUL83. We next assessed the oligomerization of endogenous
IFI16 following either WT or DUL83 HCMV infection in HFF cells.
Using a similar approach, we observed that endogenous IFI16
indeed oligomerized, shifting to higher mass following infection
with DUL83, but not with WT HCMV (Figure 2I). Therefore,
upon DNA sensing IFI16 forms oligomers via PY domain, which
are effectively blocked by pUL83.
pUL83 Contains Conserved N and C Terminus Domains
Joined by a Highly Phosphorylated Linker
To explore how pUL83 blocks PY oligomerization, we character-
ized its sequence and posttranslational modifications (PTMs).
Sequence alignment of pUL83 homologs from primate CMVs
(Figure S3A) revealed a conserved N-terminal domain (386 res-
idues), a divergent linker region, and a conserved C terminus
(CTD, 90 residues) (Figure 3A), indicating a bipartite structure.
The conservation correlated inversely with predicted disordered
scores (Figures 3A and S3B).
pUL83 is known to be phosphorylated (Roby and Gibson,
1986); however, to our knowledge, none of the phosphorylation
sites are defined or have known functions. To identify these sites
and test their roles in immune evasion, we isolated virally or
ectopically expressed pUL83 from HFFs. Mass spectrometry
analyses led to 95% pUL83 sequence coverage and identified
eight phosphorylated serine (S) or threonine (T) residues present
in both virally and ectopically expressed pUL83, and two sites
(T32 and S472) detected only in the latter (Figures 3A, S3C,
and S3D). These results suggest that most phosphorylations
are regulated by host kinases. Notably, most sites are within
the linker, with S406, T468, and S472 present at casein kinase
II-like motifs (S/TXXE/D) (Figure S3A). Collectively, our results
revealed a bipartite structure for pUL83 and numerous phos-
phorylation sites.
Phosphorylation Modulates the Pyrin-Interfering
Activity of pUL83
To test if phosphorylation modulates IFI16-PY interference
by pUL83, we performed mutagenesis to alanine (A), aspartate
(D), or glutamate (E), focusing on the three sites within the
conserved N-terminal domain. While mutations at T32 or T66
or the S364A mutation had little impact on PY interference, the
phosphomimic S364D reduced this activity (Figure 3G). As these
mutations did not affect pUL83 stability or nuclear localization
(Figures 3G and S3E), we conclude that S364 phosphorylation
can partially compromise IFI16-PY interference. This phosphor-
ylation was detected only at low levels (<1%, Figure S3F) during
infection, suggesting a minor event not affecting the majority ofMicrobe 14, 591–599, November 13, 2013 ª2013 Elsevier Inc. 595
(legend on next page)
Cell Host & Microbe
HCMV pUL83 Blocks DNA Sensing
596 Cell Host & Microbe 14, 591–599, November 13, 2013 ª2013 Elsevier Inc.
Figure 4. Working Model for IFI16-Mediated Nuclear DNA Sensing
and pUL83-Mediated Immune Evasion
IFI16 detects nuclear HCMV DNA via HIN domains, oligomerizes via the pyrin
domain, and activates STING-mediated cytokine expression. pUL83 blocks
IFI16 pyrin aggregation and hijacks IFI16 to help activate HCMV MIEP. pUL83
is partly inhibited by phosphorylation at S364. The balance between the DNA
sensing and immune evasion determines the immunological outcome of
HCMV infections.
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late pUL83 activity at the posttranslational level.
The Mechanism of pUL83-Mediated IFI16 Inhibition
Involves Its NTerminus for PyrinBinding andCTerminus
for Dissipation of Nuclear Aggregation
To map the PY-binding activity within pUL83, we generated
deletion constructs to represent combinations of the above-
defined pUL83 regions (Figure 3B). CoIP assays showed that
constructs including the entire N terminus domain could effi-
ciently bind IFI16-PY (Figure 3C, #1–#4), while loss of this
domain (#5) abolished PY binding. Therefore, the N-terminal
domain is necessary and sufficient for interaction with IFI16
PY, and we named this conserved region as pyrin association
domain (PAD). Moreover, both the first (1–200) and the second
(201–391) halves of PAD are necessary (#6 and #7) but not suffi-Figure 3. Interference of Pyrin Aggregation Requires Both the Pyrin As
(A) Schematic of pUL83 shows its bipartite structure, conservation scores, predi
(B) Schematics of pUL83 constructs; those lacking NLS (red) were supplemente
(C) Interactions of pUL83-Flag constructs in (B) (preys) with IFI16-PY-GFP (bait)
(D) PAD-mCherry and pUL83-mCherry were tested for PY interference as in Figu
(E) IF shows the ability of pUL83 constructs in (B) to interfere with IFI16-PY-GFP
(F) Two models for the role of the pUL83 linker in PY interference.
(G) Mutants of PAD phosphosites were tested for pyrin interference as in (D). St
pUL83 constructs.
(H) Predicted structure models for pUL83 (rainbow) and IFI16 Pyrin (green). Dock
(I) SDS-PAGE of recombinant complex of GST-PAD and sumo-IFI16-Pyrin.
See also Figure S3.
Cell Host &cient (#8 and #9) for strong association with IFI16-PY. These
results establish PAD as the minimal unit required for optimal
recruitment of IFI16-PY.
To see if PAD is sufficient for PY interference, we coexpressed
PAD-mCherry with PY in 293T cells. Surprisingly, PAD was not
sufficient for interfering with either IFI16- or IFIX-PY (Figure 3D),
suggesting another pUL83 region is also required. Therefore, we
tested the aforementioned pUL83 constructs (Figure 3E). Neither
PAD alone (#4) nor any PAD-deficient constructs (#5–#9) disrup-
ted IFI16-PY aggregation. Notably, the CTD-deficient pUL83 (#2)
did not disrupt aggregation, indicating that CTD is also needed
for PY interference. Strikingly, removal of the linker (#3) led to a
distinct PY distribution, displaying nuclear spheres and nucleolar
enrichment. This result implied two possible models for the role
of the pUL83 linker as: (1) a spacer that correctly positions PAD
andCTD, or (2) a direct contributor to PY interference (Figure 3F).
To test thesemodels, we replaced the native linker with a scram-
bled sequence (Figures 3B and 3E). Interestingly, this new linker
restored the PY-interfering activity, supporting the spacer
model. Collectively, our data show concerted action of the
pUL83 domains, where the PAD initially recruits PY, and the
CTD, appropriately separated by the linker, assists in dissipating
PY oligomerization.
Lastly, to understand the molecular basis for this action, we
predicted a structural model for pUL83. The model depicts an
arched shape structured by solenoid folding (Figure 3H). The
PAD contributes to most of the arch, followed by the solenoid
linker and the CTD. The arch could accommodate the size of a
PY domain, implying a one-to-one PAD-PY complex. Indeed,
we copurified a recombinant complex of GST-PAD and sumo-
tagged IFI16-PY from E. coli that appeared at equivalent ratio
(Figure 3I). The model suggests extensive contact between PY
and pUL83, consistent with the notion that both halves of PAD
are required for binding PY. The contact at CTD likely masks
critical PY surfaces needed for oligomerization. Altogether, the
predicted structure of pUL83 lends further mechanistic insights
into the pUL83-IFI16 interaction.
DISCUSSION
Here, we provide amechanistic view of the conflict between host
innate antiviral response and viral immune evasion during HCMV
infection (Figure 4). First, we establish that IFI16 is a nuclear DNA
sensor that is critical for triggering antiviral response during
HCMV infection. Early during infection, IFI16 detects nuclear
HCMV DNA, oligomerizes, and activates the STING-TBK1-
IRF3 pathway to induce antiviral cytokines. Our findings alsosociation Domain and the C-Terminal Domain of pUL83
cted disorder degrees, and phosphorylation sites.
d with SV40-NLS (orange) to ensure nuclear localization.
were tested by coIP.
re 2F; diffuse (yellow) or aggregation (blue) patterns shown as mean ± SEM.
aggregation.
atistics: ns, not significant; *p < 0.05; **p < 0.01. Western blots show levels of
ing shows arbitrary size fitting.
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plasmic STING, and what other signaling pathways may be
involved in antiviral responses. Second, we define a previously
unknown mechanism in which the viral protein pUL83 blocks
host IFI16-mediated sensing. Following cell entry, the abundant
pUL83 enters the nucleus and binds IFI16 via its pyrin domain.
Although IFI16 HIN domains can still bind viral DNA and release
the autoinhibited pyrin, pUL83 can effectively block pyrin oligo-
merization and subsequent immune signaling. Third, cellular
kinase(s) can phosphorylate pUL83 at S364, compromising its
pyrin-interfering activity. Moreover, pUL83 recruits IFI16 to the
MIEP to help activate viral gene expression (Cristea et al.,
2010). Therefore, the pUL83-IFI16 interaction is a critical hub
that modulates the outcome of HCMV infection, influencing the
balance between innate immune response that initiates viral
clearance and viral immune evasion that facilitates viral spread.
Conceivably, a pharmaceutical agent that disrupts this inter-
action would shift the balance toward DNA sensing, boosting
host immune responses to thwart HCMV infections.
Innate host sensors frequently utilize aggregation-dependent
amplification mechanisms for signaling, e.g., the DNA sensor
AIM2 (Fernandes-Alnemri et al., 2009) and RNA sensors RIG-I
and MDA-5 (Jiang et al., 2012). Here, we showed that this princi-
ple also applies to nuclear DNA sensing, as IFI16 oligomerizes
via its pyrin domain. To block pyrin oligomerization, the pUL83
PAD domain first recruits pyrin and then locks pyrin in a mono-
meric state with the help of its CTD. This action also predicts
that one pUL83molecule is needed to inhibit one IFI16molecule.
This may explain why HCMV evolved to carry pUL83 as the most
abundant virion component, delivered instantly after cell entry to
aid immune evasion. This is distinct from HSV-1 infection, which
uses the viral E3 ubiquitin ligase ICP0 to help target IFI16 for
degradation, thereby dampening type I IFN response (Orzalli
et al., 2012) and inflammatory response (Johnson et al., 2013).
In contrast, HCMV adopts a nondestructive strategy that may
suit better its longer lytic cycle. As no homologs of pUL83 are
present in other herpesvirus subfamilies, the pUL83-dependent
immune evasion is likely a specific feature of CMVs. Overall,
the distinct viral mechanisms used to target IFI16 underscore
the essential role of this nuclear DNA sensor in innate antiviral
response. Interestingly, the pUL83-mediated immune evasion
is similar to subversion of RNA sensing by paramyxoviruses,
e.g., measles, parainfluenza, and sendai viruses. Their V proteins
bind the SF2 domain of the RNA sensor MDA5, blocking its
aggregation required for immune signaling (Motz et al., 2013).
Therefore, our study points to both divergent and convergent
evolutions of viruses to breach host nucleic acids sensing
activities.
Altogether, we demonstrate that pUL83 inhibits IFI16-medi-
ated antiviral cytokine expression. Additionally, previous reports
have shown that pUL83 can indirectly contribute to immune
evasion by modulating the expression of viral immediate-early
proteins IE1 and IE2 (Cristea et al., 2010; Taylor and Bresnahan,
2006). IE1 binds STAT1/2, thereby antagonizing the antiviral
effect of IFN-b (Paulus et al., 2006). IE2 was shown to block
the HCMV-induced expression of IFN-b and antiviral chemo-
kines (Taylor and Bresnahan, 2005, 2006). The additive impact
of different viral strategies for immune evasion may contribute
to the partial suppression of DUL83 HCMV-induced cytokines598 Cell Host & Microbe 14, 591–599, November 13, 2013 ª2013 Elsby pUL83-Flag, while this could also result from insufficient
ectopic expression of pUL83. Nevertheless, our observation
that the DUL83 strain triggered substantially higher levels of anti-
viral cytokines than WT HCMV, even after UV treatment blocked
viral gene expression, demonstrated an independent role for
pUL83 in suppressing cytokine expression.
In summary, here we defined a molecular mechanism for viral
immune evasion, an important aspect of HCMV pathogenesis.
This knowledge may guide the future design of therapeutics to
restore host immune response as a possible antiviral strategy.
EXPERIMENTAL PROCEDURES
Full descriptions of materials and methods are provided in Supplemental
Experimental Procedures.
shRNA-Mediated Silencing, Viral Infections, Nuclear Fractionation,
and RNA Quantification
Lentiviral particles were produced in HEK293T cells cotransfected with
pLKO.1 shRNA vectors (Open Biosystems) and packaging vectors. HFFs
were transduced for 24 hr with resulting particles and 8 mg/mL polybrene,
and selected with 2 mg/mL puromycin. 3 3 105 HFFs were infected with
HCMV strains at moi = 5 for 3 or 6 hpi. Nuclear fractions were collected by
hypotonic lysis of cells, followed by washes and centrifugation. Protein levels
were measured by western blot. RNA levels were quantified by reverse tran-
scription and qPCR.
IFI16 Oligomerization by Microscopy and Crosslinking
PYHIN and pUL83 plasmids were constructed as detailed in Supplemental
Experimental Procedures. 293T cells were transfected with PYHIN and
pUL83 plasmids at indicated ratios using Lipofectamine 2000 (Invitrogen)
and visualized after 16 hr by confocal direct fluorescence microscopy. To
test IFI16 oligomerization, HFFs lysates were crosslinked with 5 mM glutaral-
dehyde for 10 min, quenched with 50 mM glycine, boiled in SDS buffer, and
analyzed by western blot.
IFI16-DNA Interactions by Chromatin IP
Infected HFF cells were crosslinked with 1% paraformaldehyde. Endogenous
IFI16 was immunoisolated from lysates on magnetic beads (Invitrogen)
conjugated with anti-IFI16 antibodies (Abcam). After a denaturing elution,
crosslinking was reversed at 65C overnight, and DNA was recovered by col-
umn purification and analyzed by PCR.
pUL83 Isolation and Mass Spectrometry
HFFs stably expressing pUL83-Flag or infected with HCMV UL83-TAP
(moi = 3) for 6 hr were used to immunoaffinity purify pUL83 via anti-FLAG anti-
body or IgG (TAP)-conjugated magnetic beads, as in Cristea et al. (2005). Iso-
lated proteins were digested with trypsin and analyzed by LC-MS/MS using an
LTQ Orbitrap Velos (Thermo Scientific). Raw data were searched in Proteome
Discoverer (V1.3) against a database containing human and herpesvirus
sequences (Swiss-Prot), with peptide false discovery rate of 1%, and further
refined in Scaffold 3.0 (Proteome Software).
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, one movie, and Supple-
mental Experimental Procedures and can be found with this article at http://
dx.doi.org/10.1016/j.chom.2013.10.007.
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